| Literature DB >> 21619577 |
Safarina G Malik1, Made R Saraswati, Ketut Suastika, Hidayat Trimarsanto, Sukma Oktavianthi, Herawati Sudoyo.
Abstract
BACKGROUND: Prevalence of obesity is increasing all over the world. ADRB3 Trp64Arg gene polymorphism was proposed to be associated with obesity, although inconsistent findings and differences of the Arg64 allele frequency among various ethnics were reported. Westernization was reported to increase the prevalence of obesity in developing world. In this study we determined the prevalence of obesity and metabolic syndrome among urban and rural Balinese, and studied the association of ADRB3 Trp64Arg polymorphism with obesity and MetS.Entities:
Year: 2011 PMID: 21619577 PMCID: PMC3121622 DOI: 10.1186/1756-0500-4-167
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Characteristics of study subjects
| Variables | Urban | Rural | Trp64 | Arg64 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Trp64 | Arg64 | Total | Trp64 | Arg64 | ||||||
| 282 | 249 | 33 | 246 | 220 | 26 | ||||||
| Age (years) | 46 ± 10 | 46 ± 10 | 44 ± 9 | 0.158 | 51 ± 16 | 50 ± 16 | 52 ± 15 | 0.716 | |||
| BMI (kg/m2) | 26 ± 5 | 26 ± 5 | 26 ± 5 | 0.694 | 23 ± 5 | 22 ± 5 | 24 ± 4 | 0.0928 | |||
| WC (cm) | 89 ± 11 | 88 ± 11 | 90 ± 12 | 0.384 | 80 ± 11 | 79 ± 11 | 86 ± 10 | 0.1653 | |||
| HDL-C (mg/dL) | 50 ± 11 | 51 ± 11 | 49 ± 11 | 0.369 | 52 ± 11 | 52 ± 12 | 52 ± 9 | 0.773 | 0.0931 | 0.2479 | |
| TG (mg/dL) | 149 ± 90 | 150 ± 93 | 143 ± 68 | 0.555 | 130 ± 57 | 131 ± 59 | 115 ± 43 | 0.096 | 0.0690 | ||
| SBP (mmHg) | 125 ± 8 | 125 ± 8 | 126 ± 8 | 0.481 | 123 ± 18 | 123 ± 19 | 125 ± 16 | 0.534 | 0.0748 | 0.0667 | 0.6575 |
| DBP (mm Hg) | 83 ± 11 | 83 ± 10 | 85 ± 12 | 0.452 | 79 ± 11 | 79 ± 11 | 79 ± 8 | 0.816 | |||
| FPG (mg/dL) | 98 ± 36 | 98 ± 38 | 91 ± 12 | 97 ± 14 | 97 ± 13 | 100 ± 23 | 0.549 | 0.8379 | 0.5456 | 0.0833 | |
| 178 | 157 | 21 | 128 | 113 | 15 | ||||||
| Age (years) | 46 ± 11 | 46 ± 11 | 46 ± 10 | 0.835 | 49 ± 15 | 49 ± 16 | 46 ± 12 | 0.449 | |||
| BMI (kg/m2) | 26 ± 5 | 26 ± 5 | 28 ± 5 | 0.281 | 23 ± 4 | 23 ± 4 | 24 ± 4 | 0.322 | |||
| WC (cm) | 91 ± 11 | 91 ± 10 | 94 ± 12 | 0.259 | 82 ± 11 | 82 ± 11 | 86 ± 9 | 0.156 | |||
| HDL-C (mg/dL) | 47 ± 10 | 47 ± 10 | 44 ± 10 | 0.144 | 49 ± 10 | 48 ± 10 | 50 ± 10 | 0.596 | 0.1169 | 0.3658 | 0.0747 |
| TG (mg/dL) | 170 ± 68 | 171 ± 102 | 161 ± 63 | 0.537 | 143 ± 59 | 145 ± 61 | 125 ± 37 | 0.079 | |||
| SBP (mmHg) | 129 ± 8 | 129 ± 7 | 130 ± 8 | 0.518 | 121 ± 18 | 122 ± 18 | 118 ± 13 | 0.410 | |||
| DBP (mm Hg) | 86 ± 11 | 86 ± 10 | 89 ± 13 | 0.350 | 78 ± 10 | 79 ± 11 | 76 ± 8 | 0.353 | |||
| FPG (mg/dL) | 97 ± 27 | 98 ± 29 | 89 ± 8 | 97 ± 16 | 97 ± 15 | 99 ± 25 | 0.773 | 0.9823 | 0.6333 | 0.1376 | |
| 107 | 94 | 13 | 118 | 107 | 11 | ||||||
| Age (years) | 46 ± 9 | 46 ± 9 | 41 ± 8 | 52 ± 16 | 52 ± 16 | 59 ± 17 | 0.216 | ||||
| BMI (kg/m2) | 25 ± 5 | 25 ± 5 | 24 ± 3 | 0.241 | 22 ± 6 | 22 ± 6 | 25 ± 3 | 0.5098 | |||
| WC (cm) | 84 ± 10 | 84 ± 10 | 84 ± 8 | 0.970 | 78 ± 11 | 77 ± 11 | 87 ± 11 | 0.4718 | |||
| HDL-C (mg/dL) | 56 ± 11 | 56 ± 11 | 57 ± 9 | 0.947 | 57 ± 11 | 57 ± 12 | 55 ± 8 | 0.464 | 0.8813 | 0.7853 | 0.6156 |
| TG (mg/dL) | 116 ± 62 | 116 ± 62 | 114 ± 69 | 0.921 | 116 ± 52 | 117 ± 52 | 103 ± 50 | 0.383 | 0.9866 | 0.9065 | 0.6442 |
| SBP (mmHg) | 120 ± 6 | 120 ± 7 | 121 ± 6 | 0.457 | 125 ± 19 | 124 ± 19 | 134 ± 15 | 0.070 | |||
| DBP (mm Hg) | 79 ± 9 | 79 ± 9 | 79 ± 8 | 0.930 | 80 ± 12 | 79 ± 13 | 84 ± 7 | 0.109 | 0.3407 | 0.5206 | 0.1218 |
| FPG(mg/dL) | 98 ± 46 | 98 ± 49 | 95 ± 16 | 0.594 | 97 ± 11 | 97 ± 10 | 100 ± 18 | 0.522 | 0.8036 | 0.7124 | 0.4533 |
Urban: Legian village. Rural: Penglipuran and Pedawa villages. BMI: body mass index, WC: waist circumference, HDL-C: high density lipoprotein cholesterol, SBP: systolic blood pressure, DBP: diastolic blood pressure, FPG: fasting plasma glucose. Data are means ± SD. p -values in bold: significant. p-values were calculated using the Welch's t-test.
Association of the Arg allele with BMI and WC in urban and rural
| Variables | Classification | Urban | Rural | Trp64 | Arg64 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total (%) | Trp64 (%) | Arg64 (%) | Total (%) | Trp64 (%) | Arg64 (%) | |||||||
| 282 | 249 | 33 | 246 | 220 | 26 | |||||||
| BMI | Underweight | 3 | 3 | 0 | 0.522 | 16 | 18 | 0 | 0.136 | 0.433 | ||
| Normal | 24 | 24 | 27 | 41 | 41 | 42 | ||||||
| Overweight | 22 | 22 | 21 | 18 | 18 | 19 | ||||||
| Obese I | 37 | 38 | 30 | 20 | 19 | 31 | ||||||
| Obese II | 14 | 13 | 21 | 4 | 4 | 8 | ||||||
| WC | Abdominal obesity | 62 | 61 | 67 | 0.561 | 36 | 34 | 58 | 0.479 | |||
| Non abdominal obesity | 38 | 39 | 33 | 64 | 66 | 42 | ||||||
| 175 | 155 | 20 | 128 | 113 | 15 | |||||||
| BMI | Underweight | 2 | 2 | 0 | 0.234 | 13 | 15 | 0 | 0.088 | 0.052 | ||
| Normal | 24 | 24 | 25 | 44 | 42 | 53 | ||||||
| Overweight | 16 | 16 | 15 | 16 | 19 | 0 | ||||||
| Obese I | 40 | 43 | 25 | 22 | 20 | 40 | ||||||
| Obese II | 18 | 15 | 35 | 5 | 4 | 7 | ||||||
| WC | Abdominal obesity | 56 | 55 | 60 | 0.702 | 30 | 28 | 40 | 0.352 | 0.241 | ||
| Non abdominal obesity | 44 | 45 | 40 | 70 | 72 | 60 | ||||||
| 107 | 94 | 13 | 118 | 107 | 11 | |||||||
| BMI | Underweight | 5 | 5 | 0 | 0.699 | 20 | 21 | 0 | 0.129 | 0.496 | ||
| Normal | 24 | 23 | 31 | 37 | 38 | 27 | ||||||
| Overweight | 31 | 31 | 31 | 20 | 18 | 45 | ||||||
| Obese I | 33 | 32 | 38 | 19 | 19 | 18 | ||||||
| Obese II | 7 | 8 | 0 | 4 | 4 | 9 | ||||||
| WC | Abdominal obesity | 72 | 71 | 77 | 0.671 | 43 | 39 | 81 | 0.769 | |||
| Non abdominal obesity | 28 | 29 | 23 | 57 | 61 | 9 | ||||||
BMI: body mass index, WC: waist circumference. BMI classification according to the classification of the Asia-Pacific perspective redefining obesity in adult Asian were: underweight < 18.5 kg/m2, normal 18.5-22.9 kg/m2; overweight at risk 23-24.9 kg/m2; obese I 25-29.9 kg/m2; obese II ≥ 30 kg/m2 [17]. Abdominal obesity was based on waist circumference if ≥ 90 cm in male or ≥ 80 cm in female [17]. All p-values were calculated using the Chi-square test.
Association of the Arg allele with MetS in urban and rural
| Variables | Classification | Urban | Rural | Trp64 | Arg64 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total (%) | Trp64 (%) | Arg64 (%) | Total (%) | Trp64 (%) | Arg64 (%) | |||||||
| 282 | 249 | 33 | 246 | 220 | 26 | |||||||
| MetS | MetS | 33 | 32 | 33 | 0.926 | 18 | 17 | 23 | 0.465 | 0.388 | ||
| Non MetS | 67 | 68 | 67 | 82 | 83 | 77 | ||||||
| 175 | 155 | 20 | 128 | 113 | 15 | |||||||
| MetS | MetS | 40 | 39 | 45 | 0.628 | 16 | 16 | 13 | 0.795 | |||
| Non MetS | 60 | 61 | 55 | 84 | 84 | 87 | ||||||
| 107 | 94 | 13 | 118 | 107 | 11 | |||||||
| MetS | MetS | 21 | 21 | 15 | 0.622 | 20 | 19 | 36 | 0.166 | 0.967 | 0.647 | 0.237 |
| Non MetS | 79 | 79 | 85 | 80 | 81 | 64 | ||||||
MetS: metabolic syndrome. MetS criteria were: elevated waist circumference (≥ 90 cm in men and ≥ 80 cm in women), elevated triglycerides (≥ 150 mg/dl or 1.7 mmol/l) or drug treatment for elevated triglyceride, reduced HDL-C (< 40 mg/dl or 1.0 mmol/l in males and < 50 mg/dl or 1.3 mmol/l) in females or drug treatment for reduced HDL-C, elevated blood pressure (systolic ≥ 130 or diastolic ≥ 85 mmHg) or antihypertensive drug treatment in a patient with a history of hypertension, and elevated fasting plasma glucose (≥ 100 mg/dl) or drug treatment for elevated glucose [18]. All p-values were calculated using the Chi-square test.
Comparison of MetS co-morbidities between male and female with MetS in urban and rural
| Criteria | Total | Urban | Rural | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 90 | 46 | 70 | 22 | 20 | 24 | ||||
| Elevated WC | 86 | 87 | 1 | 93 | 91 | 0.670 | 60 | 83 | 0.102 |
| Reduced HDL-C | 46 | 61 | 0.105 | 44 | 68 | 0.086 | 50 | 54 | 1 |
| Elevated TG | 83 | 76 | 1 | 81 | 86 | 0.753 | 90 | 67 | 0.083 |
| Elevated BP | 84 | 56 | 93 | 36 | 55 | 75 | 0.210 | ||
| Elevated FPG | 38 | 63 | 29 | 59 | 70 | 67 | 1 | ||
MetS criteria were: elevated waist circumference (≥ 90 cm in men and ≥ 80 cm in women), elevated triglycerides (≥ 150 mg/dl or 1.7 mmol/l) or drug treatment for elevated triglyceride, reduced HDL-C (< 40 mg/dl or 1.0 mmol/l in males and < 50 mg/dl or 1.3 mmol/l) in females or drug treatment for reduced HDL-C, elevated blood pressure (systolic ≥ 130 or diastolic ≥ 85 mmHg) or antihypertensive drug treatment in a patient with a history of hypertension, and elevated fasting plasma glucose (≥ 100 mg/dl) or drug treatment for elevated glucose [18]. p-values were calculated using the two-tails Fisher's exact test on male with MetS vs female with MetS.